Cargando…
PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429919/ http://dx.doi.org/10.1097/01.HS9.0000974540.98030.0b |
| _version_ | 1785090831283126272 |
|---|---|
| author | Eyre, Toby Martinez-Calle, Nicolas Walewska, Renata Hickey, Joe Blak, Betina Pickin, Anna Hunjan, Sukhjit Condon, Orlaith Hori, Satoshi |
| author_facet | Eyre, Toby Martinez-Calle, Nicolas Walewska, Renata Hickey, Joe Blak, Betina Pickin, Anna Hunjan, Sukhjit Condon, Orlaith Hori, Satoshi |
| author_sort | Eyre, Toby |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429919 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104299192023-08-17 PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS Eyre, Toby Martinez-Calle, Nicolas Walewska, Renata Hickey, Joe Blak, Betina Pickin, Anna Hunjan, Sukhjit Condon, Orlaith Hori, Satoshi Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429919/ http://dx.doi.org/10.1097/01.HS9.0000974540.98030.0b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Eyre, Toby Martinez-Calle, Nicolas Walewska, Renata Hickey, Joe Blak, Betina Pickin, Anna Hunjan, Sukhjit Condon, Orlaith Hori, Satoshi PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title | PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title_full | PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title_fullStr | PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title_full_unstemmed | PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title_short | PB1930: EPIC: A NON-INTERVENTIONAL, OBSERVATIONAL STUDY OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FIRST-LINE ACALABRUTINIB THROUGH THE UK EARLY ACCESS PROGRAMME. INTERIM ANALYSIS UP TO 24 MONTHS |
| title_sort | pb1930: epic: a non-interventional, observational study of chronic lymphocytic leukemia patients treated with first-line acalabrutinib through the uk early access programme. interim analysis up to 24 months |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429919/ http://dx.doi.org/10.1097/01.HS9.0000974540.98030.0b |
| work_keys_str_mv | AT eyretoby pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT martinezcallenicolas pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT walewskarenata pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT hickeyjoe pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT blakbetina pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT pickinanna pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT hunjansukhjit pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT condonorlaith pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months AT horisatoshi pb1930epicanoninterventionalobservationalstudyofchroniclymphocyticleukemiapatientstreatedwithfirstlineacalabrutinibthroughtheukearlyaccessprogrammeinterimanalysisupto24months |